Loss of constitutional heterozygosity in human cancer.
暂无分享,去创建一个
[1] H. Brauch,et al. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma , 1988, Nature.
[2] M. Capecchi,et al. Altering the genome by homologous recombination. , 1989, Science.
[3] E. Harlow,et al. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle , 1989, Cell.
[4] A. Reeve,et al. Loss of a Harvey ras allele in sporadic Wilms' tumour , 1984, Nature.
[5] P. S. St George-Hyslop,et al. Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. , 1987, Science.
[6] L. Siminovitch. On the nature of hereditable variation in cultured somatic cells , 1976, Cell.
[7] Nordling Co. A New Theory on the Cancer-inducing Mechanism , 1953 .
[8] A. Forrest,et al. ALLELE LOSS ON SHORT ARM OF CHROMOSOME 17 IN BREAST CANCERS , 1988, The Lancet.
[9] W. Cavenee,et al. Molecular Genetics in the Pathology and Diagnosis of Retinoblastoma , 1990, Brain pathology.
[10] Harold L. Moses,et al. TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights , 1990, Cell.
[11] Iqbal Unnisa Ali,et al. Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia , 1987 .
[12] Y. Nakamura,et al. Allelotype of colorectal carcinomas. , 1989, Science.
[13] J. Haines,et al. Von HippelLindau disease maps to the region of chromosome 3 associated with renal cell carcinoma , 1988, Nature.
[14] A. Knudson,et al. Mutation and cancer: a model for Wilms' tumor of the kidney. , 1972, Journal of the National Cancer Institute.
[15] M. Yanagida,et al. Distinct, essential roles of type 1 and 2A protein phosphatases in the control of the fission yeast cell division cycle , 1990, Cell.
[16] E. Blackburn,et al. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs , 1990, Nature.
[17] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.
[18] J. Cowell,et al. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11. , 1990, Oncogene.
[19] R. Martuza,et al. Molecular genetic approach to human meningioma: loss of genes on chromosome 22. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[20] R. King,et al. The role of the otu Gene in Drosophila oogenesis , 1988, BioEssays : news and reviews in molecular, cellular and developmental biology.
[21] R. Sager. Genetic suppression of tumor formation. , 1985, Advances in cancer research.
[22] J. H. Lee,et al. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. , 1990, Cancer research.
[23] W. Lee,et al. Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. , 1990, The EMBO journal.
[24] J. Boeke. Reverse transcriptase, the end of the chromosome, and the end of life , 1990, Cell.
[25] W. Lee,et al. Structure of the human retinoblastoma gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[26] G. Klein,et al. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[27] Y. Nakamura,et al. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. , 1987, Science.
[28] L. Hartwell,et al. Normal stoichiometry of histone dimer sets is necessary for high fidelity of mitotic chromosome transmission , 1986, Cell.
[29] C. James,et al. Mitotic recombination of chromosome 17 in astrocytomas. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[30] Phang-lang Chen,et al. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation , 1989, Cell.
[31] L. Foulds,et al. The natural history of cancer. , 1958, Journal of chronic diseases.
[32] P. Radice,et al. Loss of heterozygosity in human germinal tumors. , 1989, Cytogenetics and cell genetics.
[33] N C Dracopoli,et al. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Fey,et al. Clonal allele loss in gastrointestinal cancers. , 1989, British Journal of Cancer.
[35] J. Richie,et al. Regional loss of chromosome 6 in two urological malignancies. , 1989, Cancer research.
[36] A. Poustka,et al. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping , 1990, Nature.
[37] C. Sapienza. Genome Imprinting and Dominance Modification , 1989, Annals of the New York Academy of Sciences.
[38] Y. Nakamura,et al. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. , 1989, The New England journal of medicine.
[39] C. Mathew,et al. Development of multiple endocrine neoplasia type 2A does not involve substantial deletions of chromosome 10. , 1989, Genomics.
[40] C. Marshall. Tumor suppressor genes , 1991, Cell.
[41] Yumay Chen,et al. Genetic mechanisms of tumor suppression by the human p53 gene , 1990, Science.
[42] J. Fraumeni,et al. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.
[43] A. Feinberg,et al. Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. , 1989, American journal of human genetics.
[44] W. Cavenee,et al. Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[45] A. Wolf,et al. RAP1 protein interacts with yeast telomeres in vivo: Overproduction alters telomere structure and decreases chromosome stability , 1990, Cell.
[46] L. Hartwell,et al. Checkpoints: controls that ensure the order of cell cycle events. , 1989, Science.
[47] A. Gazdar,et al. Loss of heterozygosity in a gene coding for a thyroid hormone receptor in lung cancers. , 1989, American journal of human genetics.
[48] C. Larsson,et al. Genomic alterations in human breast carcinomas , 1990, Genes, chromosomes & cancer.
[49] D. Hanahan,et al. Dissecting multistep tumorigenesis in transgenic mice. , 1988, Annual review of genetics.
[50] C. M. Steel,et al. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis , 1990, The Lancet.
[51] W. Bodmer,et al. p53 mutations in colorectal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[52] J. Minna,et al. A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). , 1982, Cancer genetics and cytogenetics.
[53] M Terada,et al. Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[54] A. Feinberg,et al. Loss of genes on the short arm of chromosome 11 in bladder cancer , 1985, Nature.
[55] A. Feinberg,et al. Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours , 1984, Nature.
[56] M. Oshimura,et al. Introduction of normal chromosome 3p modulates the tumorigenicity of a human renal cell carcinoma cell line YCR. , 1990, Oncogene.
[57] A. Levine,et al. The p53 proto-oncogene can act as a suppressor of transformation , 1989, Cell.
[58] J. Haines,et al. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22 , 1987, Nature.